Glucagon-Like Peptide-1 Receptor Expression in Normal and Neoplastic Human Pancreatic Tissues

about

Effects of Pegylated Glucagon-Like Peptide-1 Analogue in C57Bl/6 Mice under Optimal Conditions and During Streptozotocin-Induced Diabetes.

P2860

Q49834271-6C1A6D10-ABA6-48A7-80DB-C419684B5B04

P2860

Glucagon-Like Peptide-1 Receptor Expression in Normal and Neoplastic Human Pancreatic Tissues

Item

http://www.wikidata.org/entity/Q36665328

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Glucagon-Like Peptide-1 Recept ...... astic Human Pancreatic Tissues

@ast

Glucagon-Like Peptide-1 Recept ...... astic Human Pancreatic Tissues

@en

type

Item

label

Glucagon-Like Peptide-1 Recept ...... astic Human Pancreatic Tissues

@ast

Glucagon-Like Peptide-1 Recept ...... astic Human Pancreatic Tissues

@en

prefLabel

Glucagon-Like Peptide-1 Recept ...... astic Human Pancreatic Tissues

@ast

Glucagon-Like Peptide-1 Recept ...... astic Human Pancreatic Tissues

@en

P1476

Glucagon-Like Peptide-1 Recept ...... astic Human Pancreatic Tissues

@en

P2093

Amanda Blackford

http://www.w3.org/2001/XMLSchema#string

Marco Dal Molin

http://www.w3.org/2001/XMLSchema#string

P2860

Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors

Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: interactions with metformin

Pharmacology, physiology, and mechanisms of incretin hormone action

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

Alogliptin after acute coronary syndrome in patients with type 2 diabetes

Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model.

Epigenomic plasticity enables human pancreatic α to β cell reprogramming.

Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice.

In situ quantitative measurement of HER2mRNA predicts benefit from trastuzumab-containing chemotherapy in a cohort of metastatic breast cancer patients

Progression model for pancreatic cancer.

P304

613-619

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MPA.0000000000000521

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rajni B. Sharma

Michael Goggins

Haeryoung Kim

P577

2016-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26495786

http://www.w3.org/2001/XMLSchema#string

P932

4783303

http://www.w3.org/2001/XMLSchema#string

Glucagon-Like Peptide-1 Receptor Expression in Normal and Neoplastic Human Pancreatic Tissues

about

P2860

P2860

Glucagon-Like Peptide-1 Receptor Expression in Normal and Neoplastic Human Pancreatic Tissues

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932